glp 3 peptide vs glp-1 GLP-3 R (GLP-1 | GIP | Glucagon) 🔥Meet GLP-THREE- THREE's innovative answer

GLP-1 RA use is associated with a greater but moderate reduction in HbA 1c and lower risk of DKA when compared with SGLT2i therapy

According to the company, patients using GLP-1 medications are increasingly seeking treatments related to facial appearance, particularly volume loss following significant weight reduction

This effect is mediated through its action on the brains appetite centers, promoting a sense of fullness and satisfaction after meals

Most users begin noticing skin firmness improvements within 4 to 8 weeks of consistent subcutaneous administration, with optimal results typically appearing after 12 weeks of use

DOI: 10.1038/s41366-026-02088-1,